tirzepatide is a glp FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Associated with Lower POAG,

Safety - May be safer than other options due to its unique mechanism

The side effect comparison helps you understand what to expect with each option

Their incidence increases with dose but typically decreases over time as the body adapts to receptor activation

Fatigue : Patients may experience low energy levels, particularly in the early stages of treatment

Educational Video References Spectrum of Restrictive & Infiltrative CM Part 1 article Spectrum of Restrictive & Infiltrative CM Part 2 article Spectrum of Restrictive & Infiltrative CM Part 1 notes Spectrum of Restrictive & Infiltrative CM Part 2 notes Restrictive CM Circ Res 2017 Echocardiography Diagnostic Criteria for Constriction Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics Constrictive Pericarditis Versus Restrictive Cardiomyopathy

Always inject into the fatty tissue on the back of the upper arm, avoiding the inner arm where nerves and blood vessels lie closer to the skin surface